Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients

Rheumatology (United Kingdom)

Volumn 54, Issue 4, 2014, Pages 748-750

  Hua, Charlotte ^a   Morel, Jacques ^a   Ardouin, Elodie ^b   Ricard, Emilie ^b   Foret, Jennifer ^c   Mathieu, Sylvain ^d   Combe, Bernard ^a   Lukas, Cédric ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c HÔPITAL PELLEGRIN   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; RITUXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTITIONER; HUMAN; INFLUENZA VACCINATION; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SPONDYLARTHRITIS; VACCINATION;

EID: 84926480446     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu531     Document Type: Letter

References (7)

1. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a populationbased study. Arthritis Rheum 2002;46:2287-93.
2. Germano V, Cattaruzza MS, Osborn J et al. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-a antagonists. J Transl Med 2014;12:77.
3. Van Assen S, Agmon-Levin N, Elkayam O et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414-22.
4. Sowden E, Mitchell WS. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord 2007;8:58.
5. Koutsogeorgopoulou L, Antoniadis C, Vassilopoulos D, Kassimos D. Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign. Clin Rheumatol 2009;28:103-4.
6. Annunziata K, Rak A, Del Buono H, DiBonaventura M, Krishnarajah G. Vaccination rates among the general adult population and high-risk groups in the United States. PLoS One 2012;7:e50553.
7. Guthmann J, Fonteneau L, Bonmarin I, Lévy-Bruhl D. Enquê te nationale de couverture vaccinale, France, janvier 2011. Couverture vaccinale contre la grippe saisonnière dans les groupes cibles et mesure de l'efficacitévaccinale. Institut de veille sanitaire. http://opac.invs.sante. fr/doc-num.php?explnum-id=7794 (10 January 2015, date last accessed).